Coronavirus (COVID-19)
Learn more
January 06, 2017
Location: Hartford Hospital's Institute of Living
This non-interventional study will examine the risks and benefits of up to 3 years of treatment with sertraline on cognition, emotional and physical development, and pubertal maturation in children ages 6 to 14 years. Recruitment Needs: Patients ages 6-14 diagnosed with an anxiety or depressive disorder that are starting sertraline or starting therapy but not taking sertraline, with an IOL psychiatrist or psychologist. This study will not alter treatment regimen. For more information about this trial, please contact: Dr. Salma Malik Phone: 860.545.7502 Email: clinical.trials@hhchealth.org
Phone: 860.545.7502
Email: clinical.trials@hhchealth.org
Get the latest healthcare news directly in your inbox.
To receive our health news text alerts / text StartHere to 85209